Key Market Indicators
The prevalence of HIV/AIDS among people aged 0-14 in Libya is expected to rise to around 600 by 2026. This is up from around 530 in 2021, an increase of 2.2% year-on-year. Since 1995, the prevalence has been rising by 1% annually. In 2021, Libya was ranked 77th in the world, with Guyana overtaking it in the rankings with 530 cases. Nigeria, Mozambique and Tanzania were the second, third and fourth-ranked countries respectively. By 2026, the treatment coverage of HIV/AIDS among people living with the virus in Libya is expected to reach 62%. This is up from 53% in 2021, an increase of 2.1 points year-on-year. Since 2005, the market has decreased by 1.4 points year-on-year. In 2021, Libya was ranked 100th in the world, with Montenegro overtaking it in the rankings with 53%. Cape Verde, Latvia and Zimbabwe were the second, third and fourth-ranked countries respectively.